StockData
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock

NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3079% below fair value
$0.71−0.04 (-5.15%)

Close on Nov 17, 2026Market cap $6.43MP/E –Yield –

Earnings

Neuroone Medical Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 16, 2027
Q1 FY2027 · estimated, before the open
Revenue, Q4 FY2026
$3.80M
+40.7% on a year earlier
EPS, Q4 FY2026
–
-$0.03 a year earlier
Latest guidance
Lowered
Aug 13, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Neuroone Medical Technologies's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2027ended Dec 31, 2026Feb 16, 2027Expected––––
Q4 FY2026ended Sep 30, 2026Oct 5, 2026before the open$3.80M+40.7%–Release
Q3 FY2026ended Jun 30, 2026Aug 13, 2026before the open$2.00M+17.6%-$0.28Release
Q2 FY2026ended Mar 31, 2026May 12, 2026before the open$2.40M+71.4%-$0.25Release
Q1 FY2026ended Dec 31, 2025Feb 17, 2026before the open$2.90M-53.2%–Release
Q4 FY2025ended Sep 30, 2025Dec 17, 2025before the open$2.70M+800.0%-$0.03Release
Q3 FY2025ended Jun 30, 2025Aug 14, 2025before the open$1.70M–-$0.03Release
Q2 FY2025ended Mar 31, 2025May 13, 2025before the open$1.40M+1.7%-$0.07Release
Q1 FY2025ended Dec 31, 2024Jan 10, 2025before the open$6.20M+533.9%–Release
Q4 FY2024ended Sep 30, 2024Dec 17, 2024before the open$300.00K-59.6%–Release
Q3 FY2024ended Jun 30, 2024Aug 14, 2024after the close––-$0.10Release
Q2 FY2024ended Mar 31, 2024May 14, 2024after the close$1.38M+195.5%-$0.11Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Neuroone Medical Technologies guided for has been reported

Guidance vs results

The last range Neuroone Medical Technologies gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2026Revenue$9.20M – $10.50M$11.10MΣ4QAbove range
FY2026Revenue growth+17%-7.5%Σ4QBelow range
FY2025Revenue$8.00M – $10.00M$12.00MΣ4QAbove range

Guidance history

Every forecast Neuroone Medical Technologies put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 13, 2026Recognized revenueFY2026$9.20M – $10.50MLowered
Feb 17, 2026product revenue increaseFY2026+17%New
Feb 17, 2026product revenueFY2026$10.50MNew
Aug 14, 2025product gross marginFY202550% – 53%New
Aug 14, 2025product revenueFY2025$8.00M – $10.00MNew
May 13, 2025product gross marginFY202547% – 51%Reaffirmed
May 13, 2025product revenue increaseFY2025+132% – +190%New
May 13, 2025product revenueFY2025$8.00M – $10.00MReaffirmed
Jan 10, 2025product gross marginFY202547% – 51%Reaffirmed
Jan 10, 2025product revenuesFY2025$8.00M – $10.00MReaffirmed
Dec 17, 2024product gross marginFY202547% – 51%New
Dec 17, 2024product revenueFY2025$8.00M – $10.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Neuroone Medical Technologies filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. Results
  4. Update
  5. Results
  6. Results
  7. Update
  8. Update
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. News

See a number that looks wrong?